On January 05, 2023 a
Exhibit,Appendix
was filed
involving a dispute between
Dan Albasry
As Trustee Of The Estate Of Newal Al Saad,
Firas Mohammad,
and
Barretts Minerals Inc.,
Beacon Cmp Corp.,
Brenntag Specialties Llc,
Charles B. Chrystal Company Inc.;,
Colgate Palmolive Co.;,
Conopco Inc.,
Glaxosmithkline Consumer Healthcare Holdings,
Glaxosmithkline Llc,
Gsk Consumer Health Inc.,
Lornamead Inc.,
Pfizer Inc.,
Port Jervis Laboratories Inc.,
The Procter & Gamble Co.,
Whittaker, Clark & Daniels Inc.,
Yardley Of London Inc.,
Yardley Of London Ltd.,,
for Torts - Asbestos
in the District Court of New York County.
Preview
) YO OU PK DM INDEX NO. 190002/2023
NYSCEF BOC. NO. 109 RECEIVED NYSCEF: 07/10/2023
EXHIBIT 24
INDEX NO. 190002/2023
NYSCEF DOC. NO. 109 RECEIVED NYSCEF: 07/10/2023
fy
yy The Cosmetic, Toiletry and Fragrance
rere
Inc.
Association,
He
4133 18th STREET, N.W., WASHINGTON, D.C. 20005 + 202/331-1770 + TELEX 89-2673 dames H. Meritt =“
Norman F. Estrin, Ph.D.
Vico Présidont—Selence
MINUTES
CIFA TALC SUBCOMMITTEE
_A meeting ofthe CTFA Talc Babdommdittes Wad he%a on July 8th, 1976
at the Chemists' Club in New York City. Those in attendance were:
George Sandland, Bristol-Myers Company (Chairman) i? e
Tryggve Baak
John Hilovsky, Mennen Company (for Robert Suffis)
Ray Krammes, Whittaker, Clark & Daniels
George Lee, Johnson & Johnson Baby Products Company
Louis Murino, Cyprus Industrial
Fred Roesch, Whittaker, Clark &- Daniels
Robert Rolle, Johnson & Johnson Baby Products Company
Joseph Simko, Colgate~Palmolive Company
Terry Smith, Faberge, Inc, Lol 7 YF ~ S $08
Ian Stewart, Walter C. McCrone
C.S8. Thompson, R.T. Vanderbilt
John Travers, Avon Products, ane
Norman Fe Estrin, CIFA
Those absent from this meeting were:
Murray Berdick, Chesebrough~Pond's Inc.
George Cohen, Bristol-Myers Company
Christopher Costello, Colgate- Palmolive Company
Allan Harvey, R.T. Vanderbilt
Roderick Mundy, Sterling Drug Company
DeWitt Petterson, Johnson & Johnson Baby Products Company
John Schelz, Johnson & Johnson Baby Products Company
Harold Stanley, Charles Pfizer
Robert Suffis, Mennen Company
Ronald Yakupein; Kolmar Laboratories, Inc.
Mr, Sandland opened the meeting by distributing a draft of a tale
standard prepared by the Toiletry Preparation Federation and briefed
the. Subcommittee on the March 3lst, 1976 minutes.
1. Tale Standard
The problem in developing a definition of ‘cosmetic tale con-
sistent with available safety data was the major subject of
discussion. The following definition was proposed and adopted
LoGiudice/WCD/0438
= INDEX NO. 190002/2023
NYSCEF DOC. NO. 109 RECEIVED NYSCEF 07/10/2023
unanimously for inclusion in the. CTPA Standard.
"“Cosinetic tale is an edseneiainy white odor-
less, fine: powder ground from naturally oc-
curring rock ore. It consists typically of
90% hydrated magnesium aluminum silicate,
having, the ideal formula Mygg¢ [Sigo29! ° (OH)4 7
with the remainder being naturally associated
minerals such as calcite, ghlorite, dolomite,
kaolin and magnesite and containing no de~
tectable asbestos minerals."
2. Animal Studies
The ultimate importance of the Industry engaging in additional
animal, studies on representative cosmetic, talcs was discussed
in detail with the Talc Subcommittee. It was noted that, at
the March 31st, 1976 meeting, it was agreed that Dr. Gressel
and Dr, Finkelstein would coordinate activities in this re-
gard. (NOTE: The Antiperspirant Task Force is coordinating
with a subcommittee of the CTFA Pharmacology & Toxicology
Committee to prepare a.protocol for a 30-day study which would
be the first step towards possible long-term studies. One
of the materials that would be tested is-an aerosolized talc.
The protocol will be sent out for bid within the next few
weeks.) Dr. Estrin was asked to investigate how long-term
testing of talcs could be financed. Fred Roesch and George
Sandland were asked to prepare a proposal for what composites
would.be representative of cosmetic tales used. That infor-
mation should be sent to Dr. Estrin for distribution to the
Subcommittee. by August lst.
3. Mt. Sinai Paper
\
Dr.. Estrin noted plans by the Mt. Sinai group to publish an
extensive paper on cosmetic talc analysis and CTFA's response
previously distributed to the Tale Subcommittee.
’
4, Mt. Sinai visit
It.was agreed that CYFA should establish dialogue with the
Mt. Sinai group. A meeting prior*to the meeting’ with the Mt.
Sinai group was agreed upon as necessary in order to discuss
the agenda. Tentative participants in such a.visit include
Tryggve Baak, Bob Rolle, Terry Smith, Ian Stewart, Dr. Estrin,
and possibly someone from FDA.
5. Miscellaneous Panel Presentation
Dr. Lee reported on the considerations of the Miscellaneous
External Drug Panel. He stated that Johnson & Johnson has
provided a transcript of its presentation to the Antiper-
spirant Panel, The review by the, Miscellaneous External. Drug
LoGiudice/WCD/0439
INDEX NO. 190002/2023
NYSCEF DOC. NO. 109 RECEIVED NYSCEF 07/10/2023
ag
has not been completed and the Panel is, presently
panel
awaiting a summary.
6. Nomenclature
consider-
The Talc Subcommittee is not, at the present time,
ing a request to the CTFA Cosmetic Ingredient, Nomenclature
for a change in nomenc lature from "Talc" to
"Cos-
Committee
metic Talc". me
The next meeting of the CIFA Ta le Subcommittee is scheduled for
September 9th, 1976 at the Chem ists’ Club in New York City at 10:30
a.m.
being no further business,, the meeting adjourned.
There
woe
LZ Kga”
ZO cz
LE
Doe PO eine
Norman F. Estrin, Ph.D.
Vice President ~ Science
Suly 12th, 1976
NFE: 33.
“
LoGiudice/WCD/0440
Preview
) YO OU PK DM INDEX NO. 190002/2023 NYSCEF BOC. NO. 109 RECEIVED NYSCEF: 07/10/2023 EXHIBIT 24 INDEX NO. 190002/2023 NYSCEF DOC. NO. 109 RECEIVED NYSCEF: 07/10/2023 fy yy The Cosmetic, Toiletry and Fragrance rere Inc. Association, He 4133 18th STREET, N.W., WASHINGTON, D.C. 20005 + 202/331-1770 + TELEX 89-2673 dames H. Meritt =“ Norman F. Estrin, Ph.D. Vico Présidont—Selence MINUTES CIFA TALC SUBCOMMITTEE _A meeting ofthe CTFA Talc Babdommdittes Wad he%a on July 8th, 1976 at the Chemists' Club in New York City. Those in attendance were: George Sandland, Bristol-Myers Company (Chairman) i? e Tryggve Baak John Hilovsky, Mennen Company (for Robert Suffis) Ray Krammes, Whittaker, Clark & Daniels George Lee, Johnson & Johnson Baby Products Company Louis Murino, Cyprus Industrial Fred Roesch, Whittaker, Clark &- Daniels Robert Rolle, Johnson & Johnson Baby Products Company Joseph Simko, Colgate~Palmolive Company Terry Smith, Faberge, Inc, Lol 7 YF ~ S $08 Ian Stewart, Walter C. McCrone C.S8. Thompson, R.T. Vanderbilt John Travers, Avon Products, ane Norman Fe Estrin, CIFA Those absent from this meeting were: Murray Berdick, Chesebrough~Pond's Inc. George Cohen, Bristol-Myers Company Christopher Costello, Colgate- Palmolive Company Allan Harvey, R.T. Vanderbilt Roderick Mundy, Sterling Drug Company DeWitt Petterson, Johnson & Johnson Baby Products Company John Schelz, Johnson & Johnson Baby Products Company Harold Stanley, Charles Pfizer Robert Suffis, Mennen Company Ronald Yakupein; Kolmar Laboratories, Inc. Mr, Sandland opened the meeting by distributing a draft of a tale standard prepared by the Toiletry Preparation Federation and briefed the. Subcommittee on the March 3lst, 1976 minutes. 1. Tale Standard The problem in developing a definition of ‘cosmetic tale con- sistent with available safety data was the major subject of discussion. The following definition was proposed and adopted LoGiudice/WCD/0438 = INDEX NO. 190002/2023 NYSCEF DOC. NO. 109 RECEIVED NYSCEF 07/10/2023 unanimously for inclusion in the. CTPA Standard. "“Cosinetic tale is an edseneiainy white odor- less, fine: powder ground from naturally oc- curring rock ore. It consists typically of 90% hydrated magnesium aluminum silicate, having, the ideal formula Mygg¢ [Sigo29! ° (OH)4 7 with the remainder being naturally associated minerals such as calcite, ghlorite, dolomite, kaolin and magnesite and containing no de~ tectable asbestos minerals." 2. Animal Studies The ultimate importance of the Industry engaging in additional animal, studies on representative cosmetic, talcs was discussed in detail with the Talc Subcommittee. It was noted that, at the March 31st, 1976 meeting, it was agreed that Dr. Gressel and Dr, Finkelstein would coordinate activities in this re- gard. (NOTE: The Antiperspirant Task Force is coordinating with a subcommittee of the CTFA Pharmacology & Toxicology Committee to prepare a.protocol for a 30-day study which would be the first step towards possible long-term studies. One of the materials that would be tested is-an aerosolized talc. The protocol will be sent out for bid within the next few weeks.) Dr. Estrin was asked to investigate how long-term testing of talcs could be financed. Fred Roesch and George Sandland were asked to prepare a proposal for what composites would.be representative of cosmetic tales used. That infor- mation should be sent to Dr. Estrin for distribution to the Subcommittee. by August lst. 3. Mt. Sinai Paper \ Dr.. Estrin noted plans by the Mt. Sinai group to publish an extensive paper on cosmetic talc analysis and CTFA's response previously distributed to the Tale Subcommittee. ’ 4, Mt. Sinai visit It.was agreed that CYFA should establish dialogue with the Mt. Sinai group. A meeting prior*to the meeting’ with the Mt. Sinai group was agreed upon as necessary in order to discuss the agenda. Tentative participants in such a.visit include Tryggve Baak, Bob Rolle, Terry Smith, Ian Stewart, Dr. Estrin, and possibly someone from FDA. 5. Miscellaneous Panel Presentation Dr. Lee reported on the considerations of the Miscellaneous External Drug Panel. He stated that Johnson & Johnson has provided a transcript of its presentation to the Antiper- spirant Panel, The review by the, Miscellaneous External. Drug LoGiudice/WCD/0439 INDEX NO. 190002/2023 NYSCEF DOC. NO. 109 RECEIVED NYSCEF 07/10/2023 ag has not been completed and the Panel is, presently panel awaiting a summary. 6. Nomenclature consider- The Talc Subcommittee is not, at the present time, ing a request to the CTFA Cosmetic Ingredient, Nomenclature for a change in nomenc lature from "Talc" to "Cos- Committee metic Talc". me The next meeting of the CIFA Ta le Subcommittee is scheduled for September 9th, 1976 at the Chem ists’ Club in New York City at 10:30 a.m. being no further business,, the meeting adjourned. There woe LZ Kga” ZO cz LE Doe PO eine Norman F. Estrin, Ph.D. Vice President ~ Science Suly 12th, 1976 NFE: 33. “ LoGiudice/WCD/0440